Biosino Bio-Technology and Science Incorporation (HKG:8247)
4.280
+0.190 (4.65%)
At close: Jan 30, 2026
Biosino Bio-Technology and Science Incorporation Company Description
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.
The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers.
It also provides medical and medical inspection services; and produces and sells medical instruments.
Biosino Bio-Technology and Science Incorporation founded in 1988 and is based in Beijing, the People’s Republic of China.
Biosino Bio-Technology and Science Incorporation
| Country | China |
| Founded | 1988 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 471 |
| CEO | Peng Chen |
Contact Details
Address: No. 27, Chaoqian Road Beijing, 102200 China | |
| Phone | 86 10 6972 2840 |
| Website | sinobio.com.cn |
Stock Details
| Ticker Symbol | 8247 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000288 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Zhengyong Chen | Executive Chairman |
| Peng Chen | President and Executive Director |
| Jianzhong Liu | Finance Director |
| Woon Cheung Tung (U.S), CPA | Company Secretary |